The International Sexual Health And Reproductive Health Survey (I-SHARE-1): A Multi-Country Analysis of Adults from 30 Countries Prior to and During the Initial COVID-19 Wave

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Preprint

    Accepted author manuscript, 2.23 MB, PDF document

  • Jennifer Toller Erausquin
  • Rayner K J Tan
  • Maximiliane Uhlich
  • Joel M Francis
  • Navin Kumar
  • Linda Campbell
  • Wei-Hong Zhang
  • Takhona G Hlatshwako
  • Priya Kosana
  • Sonam Shah
  • Erica M Brenner
  • Lore Remmerie
  • Aamirah Mussa
  • Katerina Klapilova
  • Kristen Mark
  • Gabriela Perotta
  • Amanda Gabster
  • Edwin Wouters
  • Sharyn Burns
  • Jacqueline Hendriks
  • Devon J Hensel
  • Simukai Shamu
  • Strizzi, Jenna Marie
  • Tammary Esho
  • Chelsea Morroni
  • Stefano Eleuteri
  • Norhafiza Sahril
  • Wah Yun Low
  • Leona Plasilova
  • Gunta Lazdane
  • Michael Marks
  • Adesola Olumide
  • Amr Abdelhamed
  • Alejandra López Gómez
  • Kristien Michielsen
  • Caroline Moreau
  • Joseph D Tucker
  • I-SHARE research consortium

BACKGROUND: There is limited evidence to date about changes to sexual and reproductive health (SRH) during the initial wave of COVID-19 disease. To address this gap, our team organized a multi-country, cross-sectional online survey as part of a global consortium.

METHODS: Consortium research teams conducted online surveys in 30 countries. Sampling methods included convenience, online panels, and population-representative. Primary outcomes included sexual behaviors, partner violence, and SRH service utilization, and we compared three months prior to and during policy measures to mitigate COVID-19. We conducted meta-analyses for primary outcomes and graded the certainty of the evidence using Cochrane methods.

RESULTS: Among 4546 respondents with casual partners, condom use stayed the same for 3374 (74.4%) people and 640 (14.1%) people reported a decline. Fewer respondents reported physical or sexual partner violence during COVID-19 measures (1063/15144, 7.0%) compared to the period before COVID-19 measures (1469/15887, 9.3%). COVID-19 measures impeded access to condoms (933/10790, 8.7%), contraceptives (610/8175, 7.5%), and HIV/STI testing (750/1965, 30.7%). Pooled estimates from meta-analysis indicate during COVID-19 measures, 32.3% (95% CI 23.9-42.1) of people needing HIV/STI testing had hindered access, 4.4% (95% CI 3.4-5.4) experienced partner violence, and 5.8% (95% CI 5.4-8.2) decreased casual partner condom use (moderate certainty of evidence for each outcome). Meta-analysis findings were robust in sensitivity analyses that examined country income level, sample size, and sampling strategy.

CONCLUSIONS: Open science methods are feasible to organize research studies as part of emergency responses. The initial COVID-19 wave impacted SRH behaviors and access to services across diverse global settings.

Original languageEnglish
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume75
Issue number1
Pages (from-to)e991–e999
Number of pages9
ISSN1058-4838
DOIs
Publication statusPublished - 2022

Bibliographical note

© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

ID: 304360438